Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.830
+0.130 (2.77%)
May 20, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$19.60
Upside
+305.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $17 | Buy | Initiates | $17 | +251.97% | May 14, 2026 |
| Citizens | Citizens | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +417.60% | May 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $14 | Buy | Initiates | $14 | +189.86% | Apr 16, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +293.37% | Dec 23, 2025 |
| Citizens | Citizens | Buy Initiates $20 | Buy | Initiates | $20 | +314.08% | Nov 3, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +376.19% | Sep 3, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2025 |